Glia: From Passive Glue to Excitable Cells When neuroglia were first described, there was considerable debate as to whether neuroglia were a connective tissue or a true population of cells (Somjen, 1988) . While this issue was resolved in the late 1800s, little attention was paid to the role of glia in neurophysiology for nearly a century. During this period, neuroscientists generally considered glia as chemical and physical insulators that enabled neurons to carry out the diverse functions of the brain. This view was reinforced by the findings of early neurophysiologists who impaled glial cells with sharp electrodes and found only passive membrane currents. Given the large fraction of brain contributed by glia, the prevailing view until the early 1970s was that over half of the mammalian brain was, in effect, silent. This view began to change as investigators found that glial cells in culture exhibited a large number of G protein-coupled receptors (GPCRs) linked to a diverse array of intracellular signaling cascades (McCarthy and de Vellis, 1978; van Calker and Hamprecht, 1981; van Calker et al., 1978) . Concerns about the expression of GPCRs by glia being a ''culture'' phenomenon were put to rest as it was demonstrated that glia in situ and in vivo also express GPCRs (Porter and McCarthy, 1997) . Today, it is generally accepted that glia throughout the brain and spinal cord as well as peripheral glia residing within ganglia and aligning axons express members of most of the different families of GPCRs known to be expressed by neurons (Porter and McCarthy, 1997) . Stimulation of these GPCRs evokes a variety of glial cell responses, the most studied of which is elevation of intracellular calcium (Ca 2+ ) concentration that is widely considered a form of glial excitability. The question is no longer whether glia exhibit GPCRs, but under what conditions are these GPCRs activated and what is the role of glial GPCR-mediated signaling in neurophysiology?
Astrocytes Are the Predominant Glial Cell Type in the Central Nervous System Like the term ''neuron,'' glia refers to a diverse set of cell types that are likely to carry out distinct functions in neurophysiology.
There are four major groups of glial cells in the nervous system: (1) Schwann cells and oligodendrocytes, which produce and wrap layers of myelin around axons in the peripheral and central nervous systems, respectively; (2) microglia, the immune cell type of the nervous system, which participate in inflammatory responses; (3) nerve/glial antigen 2 (NG2)-positive glia, which include oligodendrocyte and astrocyte progenitor cells as well as NG2 + cells that persist in the mature brain; and (4) astrocytes. Astrocytes are found throughout the brain and spinal cord and, on the basis of number, surface area, and volume, are the predominant glial cell type. There are many distinct subsets of astrocytes that can be distinguished on the basis of their morphology and biochemical characteristics. For example, Mueller glia in the retina and Bergmann glia in the cerebellum are generally grouped with astrocytes because of their expression of glial fibrillary acidic protein (GFAP) but exhibit striking differences in morphology, pharmacology, and physiology (Grosche et al., 1999 (Grosche et al., , 2002 Metea and Newman, 2006; Pinto and Gotz, 2007) . It is likely that, even within a localized brain region, adjacent astrocytes that appear identical morphologically and immunocytochemically may vary in their expression of GPCRs and their response to activation of GPCRs. While such diversity is generally accepted when considering neurons, it is rarely taken into account when interpreting data derived from astrocytes.
Protoplasmic astrocytes are the most common type of astrocytes. These cells exhibit a very complex morphology and contact most, if not all, other cell types in the brain and spinal cord. The morphology of an astrocyte resembles a bush with processes radiating out from a central cell body ( Figure 1A ). Within the CA1 stratum radiatum of the hippocampus, an individual astrocyte has a soma diameter of 7-9 mm and, with its fine processes, occupies a volume of 66,000 mm 3 (Bushong et al., 2002) . Interestingly, individual astrocytes tend to occupy distinct, nonoverlapping domains ( Figure 1A ) (Bushong et al., 2002) . The fine processes of an individual astrocyte are connected to one another through reflexive gap junctions and to other astrocytes via gap junctions at their boundaries. Patchclamping a single astrocyte with an electrode filled with a gapjunction-permeable dye rapidly leads to the filling of hundreds, if not thousands, of astrocytes (Konietzko and Muller, 1994) . Astrocytes likely function as a syncytium contacting essentially all other cellular elements in brain, including neurons, oligodendrocytes, NG2 + cells, microglia, and vasculature. A striking feature of astrocytes is that processes from a single astrocyte can envelop approximately 140,000 synapses ( Figure 1B ) (Bushong et al., 2002) , while >99% of the cerebrovascular surface is ensheathed by astrocyte processes (Kacem et al., 1998; Rama Rao et al., 2003; Simard et al., 2003; Haydon and Carmignoto, 2006; Takano et al., 2006) . In addition to the diversity among astrocytes, there may be substantial diversity within individual astrocytes with respect to interactions with the local environment. For instance, it is possible that, within a single astrocyte, a subset of processes interacts autonomously with a neighborhood of neuronal synapses, while other regions of that astrocyte interact with different groups of synapses or with other cellular elements, such as the cerebrovasculature. Further, under physiological conditions, these local regions of interaction (microdomains) of an astrocyte may not always communicate with one another. Understanding how the different microdomains of astrocytes interact with neighboring cellular elements will be critical to determining their role in neurophysiology and neuropathology.
Neuron-Astrocyte Interactions
The morphology of astrocytes places them in a unique situation to be able to listen to and respond to most cellular elements. Astrocytes exhibit a large number of GPCRs linked to Ca 2+ mobilization from internal stores, most of them being G q -coupled GPCRs (G q GPCRs). While these receptors can be experimentally activated in situ by exogenous application of agonists McCarthy, 1995a, 1995b) , they are also activated by neurotransmitters released from presynaptic terminals (Araque et al., 2002; Kang et al., 1998; Navarrete and Araque, 2008; Pasti et al., 1997; Perea and Araque, 2005; Porter and McCarthy, 1996) . This finding is relevant because it demonstrates the existence of neuron-to-astrocyte communication and that astrocytic G q GPCRs appear to be a primary link between neuronal activity and astrocytic Ca 2+ elevations. Evidence for a reciprocal effect of astrocytes on synaptic transmission through the G q GPCRmediated Ca 2+ -dependent release of neuroactive molecules (called gliotransmitters) was reported in vitro and in situ when G q GPCR agonist application elicited Ca 2+ increases in astrocytes, which correlated to changes in neuronal ionotropic glutamate receptor (iGluR) activity (Parpura et al., 1994; Pasti et al., 1997) . Since these reports, several laboratories have reported that Ca 2+ elevations in a small fraction of astrocytes and under certain conditions in situ can result in the release of gliotransmitters, including glutamate, ATP, and D-serine, that bind to preand/or postsynaptic neuronal receptors to modulate synaptic transmission and activity (Bezzi et al., 1998; Fiacco and McCarthy, 2004; Kang et al., 1998; Lee et al., 2007; Mothet et al., 2005; Navarrete and Araque, 2008; Pascual et al., 2005; Serrano et al., 2006; Yang et al., 2003) . Thus, it appears that astrocytes in situ not only listen and react to ongoing neuronal activity but also have the ability to modulate this activity via the release of gliotransmitters. The recognition of the bidirectional communication between neurons and astrocytes at the synapse led to the concept of the ''tripartite synapse'' (Figure 2) , in which the astrocyte, in addition to pre-and postsynaptic compartments, is a functional component of the synapse. A primary focus of this review is to discuss recent findings that have shaped our current understanding of the role of astrocyte G q GPCR-mediated Ca 2+ elevations on neuronal-astrocyte communication, focusing on the concept of ''gliotransmission'' and discussing both the issues that are well accepted and the ones that are currently in dispute. (A) View of two neighboring astrocytes in the CA1 area of hippocampus labeled with different colored fluorescent dyes (Alexa 488, green; Alexa 568, red). The elaborate and dense processes of each astrocyte do not overlap, and peripheral fine terminal processes interdigitate with one another (yellow). Pyramidal CA1 neurons appear in blue. (B) View of an astrocyte (green) extending its highly ramified processes in close proximity to a CA1 neuronal dendrite (red). These processes can cover most synapses in the astrocyte domain. Panel (A), courtesy of M.H. Ellisman; panel (B), modified from Fiacco and McCarthy (2004) .
Mechanisms of Ca
2+ Increases in Astrocytes The most widely accepted mechanism for astrocytic Ca 2+ increases is the canonical phospholipase C (PLC)/inositol 1,4,5-trisphosphate (IP 3 ) pathway. Upon G q GPCR activation, PLC hydrolyzes the membrane lipid phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol (DAG) and IP 3 , leading to IP 3 receptor (IP 3 R) activation and Ca 2+ release from the endoplasmic reticulum (ER). This is based on an exhaustive amount of data from both cultured astroglia and in situ astrocytes and has been the subject of numerous reviews (Fiacco and McCarthy, 2006; Parri and Crunelli, 2003; Scemes, 2000; Scemes and Giaume, 2006; Volterra and Steinhauser, 2004) . Using a knockout (KO) of the IP 3 R type 2 (IP 3 R2), it has been recently demonstrated that, within the hippocampus, IP 3 R2 is the primary functional IP 3 R subtype in astrocytes in situ (Petravicz et al., 2008) . These data are consistent with data in cultured astroglia showing that Ca 2+ release sites correlate with IP 3 R2 immunostaining and that IP 3 R2 associates with other members of the PLC/IP 3 pathway in lipid rafts (Sheppard et al., 1997; Weerth et al., 2007) . In addition, immunostaining for IP 3 Rs in rodent brain sections indicates that astrocytes express primarily IP 3 R2, while type 1 and 3 IP 3 Rs are preferentially found in neurons (Hertle and Yeckel, 2007; Holtzclaw et al., 2002; Sharp et al., 1999) .
While the mechanisms of astrocytic Ca 2+ increases in response to G q GPCR activation are relatively well understood, less is known about (1) how astrocytic second messenger pathways may be regulating the spatiotemporal dynamics of G q GPCR-mediated Ca 2+ transients and (2) (Foskett et al., 2007) . Furthermore, studies of the DAG/protein kinase C (PKC) pathway indicate that PKC is involved in the termination of astrocytic Ca 2+ transients (Codazzi et al., 2001; Parri and Crunelli, 2003) . While the molecular target of PKC phosphorylation remains unknown, the two most likely candidates are either G q GPCRs or the IP 3 R itself. Further research into second messenger regulation will provide a better understanding of the signaling mechanisms governing astrocyte PLC-dependent Ca 2+ regulation.
Astrocytic Ca 2+ elevations following stimulation of neuronal afferents are attributed to activation of astrocytic G q GPCRs and not to activation of voltage-gated Ca 2+ channels (VGCCs) (Beck et al., 2004; Carmignoto et al., 1998; Duffy and MacVicar, 1994; Jabs et al., 1994; Nett et al., 2002; Parri and Crunelli, 2003; Porter and McCarthy, 1995b; Straub et al., 2006) . However, while astrocytic VGCCs do not seem to play a role in the initiation of evoked astrocytic Ca 2+ increases, they may be important for initiating Ca 2+ oscillations that occur independent of neuronal input, generally referred to as spontaneous or intrinsic astrocytic Ca 2+ oscillations (Aguado et al., 2002; Parri et al., 2001; Parri and Crunelli, 2003) . To date, there is little convincing evidence that astrocytes in situ exhibit ryanodine receptor-mediated increases in Ca 2+ (Beck et al., 2004; Carmignoto et al., 1998; Nett et al., 2002; Parri and Crunelli, 2003; Porter and McCarthy, 1995b; Straub et al., 2006 ). However, it remains possible that this alternate Ca 2+ source could be important in the fine processes of astrocytes where it is difficult to study Ca 2+ regulation. Overall, the field as a whole is only beginning to appreciate the complexity of signaling molecules activated when astrocytic G q GPCRs are stimulated and how these molecules, together with Ca 2+ , shape the cellular response.
Tools for Studying Astrocytic Ca
2+ Responses In spite of the fact that astrocytic signaling has been studied for nearly three decades, very little is known concerning the role of astrocytic G q GPCRs in neurophysiology. Our lack of progress in this area stems, in large part, from the difficulty in selectively activating or blocking astrocytic G q GPCRs in situ or in vivo. Astroglial Ca 2+ signaling can easily be assessed in vitro using The presynaptic and postsynaptic compartments together with the enveloping astrocytic process form the tripartite synapse. Neurotransmitters released from presynaptic terminals act on postsynaptic receptors and astrocytic G q GPCRs following spillover from the synaptic cleft. Astrocytic G q GPCR-mediated Ca 2+ elevations may trigger the release of gliotransmitters through unresolved pathways. Astrocyte-released gliotransmitters may then signal back to neurons by activating presynaptic or postsynaptic (extrasynaptic) neuronal receptors to modulate synaptic transmission. purified cultured astroglia. However, most investigators in the field acknowledge that cultured astroglia present a very poor model for studying the functions of astrocytic G q GPCRs in situ or in vivo. For example, the morphological characteristics of astrocytes in situ are lost in cultured astroglia. In addition, cultured astroglia express genes that are not necessarily expressed in vivo, favoring the concept of a ''glial'' cell class, while the gene profiles of different subpopulations of astrocytes are dissimilar in situ (Cahoy et al., 2008; Lovatt et al., 2007; Wilhelm et al., 2004) . Consequently, acutely isolated brain slices have been utilized to study astrocytic G q GPCR-mediated Ca 2+ dynamics. In this situation, it is possible to load astrocytes with Ca 2+ indicator dyes by either bulk loading with membrane-permeable Ca 2+ indicator dyes or patch-clamp pipette loading with membrane-impermeable dyes. Bulk loading in situ preferentially loads astrocytes relative to neurons (Porter and McCarthy, 1995b) . However, until the recent development of two-photon microscopy, bulk loading has not been useful for studying Ca 2+ signaling in the processes of astrocytes due to the high fluorescent background within the neuropil. This is a serious technical limitation when using conventional fluorescence microscopy, given that the cell body constitutes a very small proportion of an astrocyte, and most neuronal-astrocyte interactions involving G q GPCR signaling are likely to initiate at neurotransmitter release sites within the neuropil. Additionally, while there is evidence that most Ca 2+ indicator dyes preferentially bulk load into astrocytic cell bodies, this may not be the case in the neuropil, where the small-diameter processes of many cell types may load with dye. There are two advantages to using patch-clamp pipettes to load astrocytes with Ca 2+ indicator dye. First, patch-clamp electrode recordings of electrophysiological properties are the best way to definitively distinguish between the two primary subtypes of GFAP-positive cells observed in immature (postnatal day 6-20) rat and mouse brain slices: the passive astrocytes, which are the subject of this review, and the so-called ''complex'' glia, which exhibit voltage-and timedependent electrical currents in situ (Jabs et al., 2005; Lin and Bergles, 2004; Matthias et al., 2003) . Second, because of the decrease in neuropil loading, it is possible to examine Ca 2+ signaling in small astrocytic compartments.
A difficulty in studying astrocytic signaling in situ or in vivo is the fact that astrocytes and other neural cells (e.g., neurons, microglia, NG2 + glia) exhibit a similar array of G q GPCRs linked to Ca 2+ mobilization. As a consequence, it is very difficult to determine the effect of selectively stimulating astrocytic Ca 2+ signaling cascades on physiological processes such as synaptic transmission. Approaches used to selectively increase astrocytic Ca 2+ include mechanical stimulation with glass electrodes (Kozlov et al., 2006) ; strong, nonphysiological depolarization of astrocytes (Jourdain et al., 2007; Kang et al., 1998) ; use of agonists to endogenous G q GPCRs (Lee et al., 2007; Navarrete and Araque, 2008; Pasti et al., 1997) ; uncaging caged IP 3 or Ca 2+ that was loaded via patchclamp pipettes into astrocytes Fiacco and McCarthy, 2004; Liu et al., 2004; Perea and Araque, 2007) ; or stimulation of a transgenic G q GPCR known to be restricted to astrocytes and whose ligand fails to activate endogenous G q GPCRs (Fiacco et al., 2007) (Figure 3 ). There are caveats associated with each of these approaches. However, there is particular concern about using mechanical stimulation where responses are likely to reflect cellular damage. The use of agonists to endogenous G q GPCRs to evoke Ca 2+ increases from internal stores in astrocytes is also problematic given that it is nearly impossible to rule out the presence of the same G q GPCRs on alternate cells. Consequently, application of a G q GPCR agonist directly stimulates these receptors on surrounding cells (e.g., neurons), making interpretation of the findings difficult. Uncaging Ca 2+ or IP 3 that was selectively loaded into astrocytes at first appears to be an excellent approach for assessing the role of Ca 2+ signaling in astrocytes. Many laboratories have used this approach to demonstrate that increases in astrocytic Ca 2+ can lead to gliotransmitter release that affects the activity of neighboring neurons Fiacco et al., 2004; Liu et al., 2004; Perea and Araque, 2007) . However, there are also caveats associated with this approach. First, uncaging either Ca 2+ or IP 3 within astrocytic cell bodies leads to an intracellular Ca 2+ wave that moves rapidly throughout the entire astrocyte from the soma into the processes. This fails to mimic the spatiotemporal dynamics and magnitude of Ca 2+ increases normally observed when activating endogenous astrocytic G q GPCRs with bath application of agonists or following stimulation of neuronal fibers (Fiacco et al., 2007; Grosche et al., 1999; Wang et al., 2006 In order to circumvent a number of these caveats, genetically modified mice that enable either selective activation or inactivation of G q GPCR-mediated Ca 2+ signaling in astrocytes were developed. The first of these lines was made using the MrgA1 receptor (MrgA1R) (Fiacco et al., 2007) that is normally expressed in a subset of dorsal root ganglion nociceptive sensory neurons but is not expressed in brain (Dong et al., 2001 ). The synthetic ligand that activates the MrgA1R has no apparent effect on endogenous brain G q GPCRs, and MrgA1Rs do not appear to respond to endogenous ligands released in the brain. The advantage of this approach is that it is possible to specifically activate the fabric of G q GPCR second messenger signaling molecules in a large population of astrocytes. A potential disadvantage of the transgenic approach is that G q GPCR transgenes are driven by a heterologous promoter (i.e., a fragment of the human GFAP promoter), which could affect the level and/or the spatiotemporal characteristics of GPCR transgene expression. With respect to the spatial expression of the MrgA1R transgene, this does not appear to be a significant problem. Activation of MrgA1Rs and endogenous metabotropic glutamate receptors (mGluRs) leads to increases in Ca 2+ that originate from the same spatial location within astrocyte processes and move as an intracellular Ca 2+ wave with the same speed from this location (Fiacco et al., 2007) . These results suggest that the same clustered signaling molecules required for Ca 2+ release from internal stores are activated by both endogenous astrocytic G q GPCRs and transgenic astrocytic MrgA1Rs. The fact that MrgA1R responses behave similarly to endogenous mGluRs suggests that MrgA1Rs are likely functional in astrocytes. However, the possibility of loss of cellular regulatory mechanisms or changes in the downstream signaling molecules necessary for initiating astrocyte responses cannot be entirely ruled out.
Another genetically modified mouse line was made by knocking out the IP 3 R2 to selectively block G q GPCR-dependent changes in astrocytic Ca 2+ . Hippocampal astrocytes derived from these mice do not respond to agonists that activate G q 
Astrocytes Listen to Neuronal Conversations In Situ
The number of different types of GPCRs expressed by astrocytes in situ is striking. For instance, hippocampal CA1 stratum radiatum astrocytes respond to application of ligands that activate purinergic, adrenergic, muscarinic, glutamatergic, GABAergic, histaminergic, endothelin, endocannabinoid, bradykinin, thrombin, opiate, and substance P receptors with an increase in Ca 2+ (Bowser and Khakh, 2007; Duffy and MacVicar, 1995; Fiacco et al., 2007; Lee et al., 2007; Navarrete and Araque, 2008; Pasti et al., 1997; Porter and McCarthy, 1997; Serrano et al., 2006; McCarthy, 1999, 2000; Verkhratsky et al., 1998 ). An individual astrocyte within the hippocampus can respond to at least four different neuroligands (Shelton and McCarthy, 2000) . It remains unclear whether different astrocytic GPCRs on a single cell regulate different physiological processes. In situ, communication from neurons to astrocytes is generally thought to be mediated by spillover of neurotransmitter from the synaptic cleft to activate astrocytic GPCRs or from neurotransmitter released from ectopic sites along axons. Neuronally mediated astrocyte Ca 2+ elevations have been shown in different brain areas, including the hippocampus, cerebellum, and retina. In hippocampal brain slices, electrical stimulation of neurons elicits Ca 2+ rises in neighboring astrocytes (Araque et al., 2002; Kang et al., 1998; Navarrete and Araque, 2008; Pasti et al., 1997; Perea and Araque, 2005; Porter and McCarthy, 1997) . Astrocytic Ca 2+ responses can be evoked by the release of a number of different transmitters from neurons, activating glial mGluRs Pasti et al., 1997; Perea and Araque, 2005; Porter and McCarthy, 1996) , g-amino-butyric-acid B (GABA B ) receptors (Kang et al., 1998) , muscarinic acetylcholine receptors (Araque et al., 2002; Perea and Araque, 2005) , and endocannabinoid receptors (Navarrete and Araque, 2008) . In the cerebellum, electrical stimulation of cerebellar parallel fibers or neurons in the granule cell layer elicits Ca 2+ increases in Bergmann glial cells; these responses appear to be mediated by nitric oxide or activation of a-adrenergic, purinergic, mGluR1, and/or AMPA receptors (Beierlein and Regehr, 2006; Grosche et al., 2002; Kulik et al., 1999; Matsui and Jahr, 2004; Matsui et al., 2005; Matyash et al., 2001; Piet and Jahr, 2007) . In the isolated rat retina, neuron-to-glial signaling occurs in response to physiological stimuli (light flashes) and is mediated by neuronal release of adenosine triphosphate (ATP) and activation of glial purinergic receptors (Newman, 2005 
Neuron
Review Ca 2+ activity persists when neuronal miniature and action-potential-mediated synaptic release is blocked, suggesting that astrocytes might be able to initiate dialog in the absence of neuronal input (Nett et al., 2002) . This astrocyte Ca 2+ activity is considered intrinsic to the astrocyte and may be driven by constitutive G q GPCR activity. In the presence of neuronal activity, spontaneous astrocytic Ca 2+ oscillations are synchronized by active neuronal networks (Aguado et al., 2002) .
Neuronal-Mediated Increases in Astrocytic Ca 2+ In Vivo
Recent studies in vivo demonstrate that astrocytes exhibit both spontaneous Ca 2+ increases (Hirase et al., 2004; Nimmerjahn et al., 2004; Wang et al., 2006) and Ca 2+ responses to neuronal activity (Bekar et al., 2008; Dombeck et al., 2007; Gobel et al., 2007; Hirase et al., 2004; Schummers et al., 2008; Wang et al., 2006) . It is worthwhile noting that, in the cerebral cortex in vivo, frequent spontaneous Ca 2+ elevations have been detected in the soma of astrocytes under basal conditions (without evoked synaptic transmission), suggesting that Ca 2+ elevations initiating in astrocyte processes are able to propagate to the soma without any apparent need for elevated levels of neuronal activity (Hirase et al., 2004; Nimmerjahn et al., 2004) . However, one study demonstrated that spontaneous Ca 2+ increases in astrocytic cell bodies were rare, while in contrast, Ca 2+ activity was much more frequent and dynamic in astrocyte processes or vascular endfeet . These discrepancies in the literature may be explained in part by the use of different ranges of (1) Ca 2+ dyes and techniques used to load astrocytes, (2) confocal/twophoton laser power, and/or (3) anesthetic concentration. Increased two-photon laser power has been reported to increase the frequency of Ca 2+ oscillations , while small increases in anesthetic concentration could produce a dramatic reduction in astrocyte responses (Hirase et al., 2004; Schummers et al., 2008) . Use of anesthetics has also been shown to greatly reduce overall brain activity and markedly affect several forms of neural dynamics (Dombeck et al., 2007) . It is also likely that different subpopulations of astrocytes, or different microdomains within astrocyte processes, will exhibit different levels of Ca 2+ activity. Overall, the magnitude, frequency, and pattern of spontaneous Ca 2+ dynamics observed in astrocytes in vivo are qualitatively similar to those described in acute slice preparations (Hirase et al., 2004; Nimmerjahn et al., 2004; Wang et al., 2006) . In addition, coordination of cortical astrocyte spontaneous Ca 2+ events is observed, suggesting that networks of coactive astrocytes occur in the cerebral cortex in vivo under basal neuronal activity (Hirase et al., 2004) , similar to what was observed previously in situ (Aguado et al., 2002) . Several studies have investigated whether astrocytes respond to physiological stimuli in vivo. Astrocytes in the barrel cortex of anesthetized adult mice promptly respond to whisker stimulation with increases in Ca 2+ in both processes and cell bodies . Increases in astrocytic somatic Ca 2+ were delayed by 3 s after the onset of whisker stimulation. Calcium increases in the processes occurred 1 s earlier than those in the soma, suggesting that the Ca 2+ increases likely initiated in the fine processes that wrap presynaptic boutons. The number of astrocytes showing increases in Ca 2+ was dependent on the frequency of whisker stimulation. Inhibition of mGluRs reduced astrocytic Ca 2+ responses to sensory stimulation, indicating that synaptic release of glutamate is a key mediator of neuron-to-astrocyte signaling in barrel cortex. Another study used two-photon imaging of Ca 2+ signals in the anesthetized adult ferret visual cortex in vivo to discover that astrocytes exhibit robust somatic Ca 2+ responses to visual stimuli that are dependent on stimulus features and have many of the receptive-field characteristics of neurons (Schummers et al., 2008) . The astrocyte responses were delayed roughly 3-4 s from stimulus onset, suggesting the occurrence of a neuron-to-astrocyte communication. A third study performed on anesthetized adult mice demonstrated that astrocytes throughout the somatosensory cortex respond to robust foot stimulation via norepinephrine release from the locus coeruleus, with Ca 2+ responses peaking within 6 s of stimulation (Bekar et al., 2008) . Finally, in a fourth study using awake, mobile, adolescent mice, somatic Ca 2+ transients from large neuronal and astrocytic populations in sensory cortex were routinely measured and correlated with running behavior (Dombeck et al., 2007) . The running-correlated astrocyte Ca 2+ elevations were delayed by 1-2 s from the onset of running. The astrocyte Ca 2+ signals were qualitatively similar to that seen in anesthetized animals in vivo in response to physiological whisker stimulation, visual stimuli, or foot stimulation (Schummers et al., 2008; Wang et al., 2006) . In conclusion, in vivo studies have led to a wealth of information regarding astrocyte activity and, most importantly, demonstrate that neuronal-to-astrocyte signaling occurs spontaneously or during elevated levels of neuronal activity in vivo.
Localized Signaling Domains and Intracellular Ca 2+ Waves
Application of a G q GPCR agonist leads to increases in astrocytic Ca 2+ that initiate at specific sites within the processes and then spread into other regions of the astrocyte (Fiacco et al., 2007; Sheppard et al., 1997; Yagodin et al., 1994 Yagodin et al., , 1995 . Intracellular Ca 2+ waves have been observed in many different cell types and are thought to propagate along organized clusters of IP 3 Rs on the membrane of the ER Thomas et al., 2000; Sheppard et al., 1997; Shuai and Jung, 2003; Roth et al., 1995; Weerth et al., 2007) . Studies in vitro and in situ indicate that stimulation of different G q GPCRs evokes Ca 2+ elevations initiating within the same region of astrocyte processes and traveling in the same pattern through the astrocytic volume (Fiacco et al., 2007; Yagodin et al., 1994) . Similar data have also been reported in other cell types, including oligodendrocytes Thomas et al., 2000) . transients in the soma (Matyash et al., 2001) . Recent in vivo studies demonstrate that robust physiological stimuli can evoke astrocytic Ca 2+ responses that initiate in cortical astrocyte processes and then propagate rapidly to the soma (Bekar et al., 2008; Wang et al., 2006) . In addition, astrocytes in the visual cortex in vivo respond to visual stimuli with cytosolic increases in Ca 2+ that are sharply tuned for stimulus orientation and spatial frequency. Such a sharp tuning of astrocytes suggests the possibility that a high level of local neuronal activity is necessary to elicit astrocyte responses (Schummers et al., 2008) . If astrocytes had a higher proportion of processes and/or a higher density of G q GPCRs clustered in microdomains adjacent to the strongest synapses, this could effectively increase (1) astrocyte response selectivity and (2) the chance for an intracellular Ca 2+ wave to initiate and propagate to reach the cell body. However, considering astrocyte diversity within the same or different brain regions, it is possible that some subsets of astrocytes respond differently to neuronal inputs, either preferentially undergoing localized Ca 2+ transients or being more susceptible to exhibiting intracellular Ca 2+ waves.
Astrocyte Intercellular Ca 2+ Waves In the early 1990s, a series of papers from Steven Smith's laboratory demonstrated intra-and intercellular Ca 2+ waves propagating through an astrocytic syncytium in cultured astroglia (Cornell-Bell et al., 1990; Dani et al., 1992) . These papers set in motion the idea that intercellular Ca 2+ waves could be a mechanism whereby astrocytes convey information over long distances in the brain. While the idea that astrocytes signal over long distances via Ca 2+ waves is attractive, there is little evidence to suggest that this actually occurs in situ or in vivo during physiological levels of activity. 
The Concept of Gliotransmission
In general, gliotransmission refers to the process whereby astrocytes release gliotransmitters (e.g., glutamate, ATP, D-serine) to affect synaptic activity (Halassa et al., 2007) . Astrocytic release of glutamate and ATP has been the most extensively studied. Early findings derived from cultured astroglia demonstrated that these cells release a number of gliotransmitters in response to brief exposure to hypotonic solutions (Kimelberg et al., 1990) . At the time, these findings were thought to reflect processes that occurred following brain trauma. More recent studies suggest that cultured astroglia release gliotransmitters via a number of different mechanisms, including swelling-induced activation of volume-regulated anion channels (Kimelberg et al., 2006) , connexin hemichannels (Kang et al., 2008; Stout et al., 2002; Ye et al., 2003) , pore-forming P2X 7 purinergic receptors Fellin et al., 2006) , and reversal of glutamate transporters (Anderson and Swanson, 2000) . In each of these situations, it is likely that the release mechanism is Ca 2+ independent and active primarily under pathological conditions. However, recent data now suggest that a fraction of astrocytes in situ release neuroactive molecules in a Ca 2+ -dependent manner to affect synaptic transmission via pre-and postsynaptic mechanisms (Bezzi et al., 1998; Fiacco and McCarthy, 2004; Kang et al., 1998; Lee et al., 2007; Mothet et al., 2005; Navarrete and Araque, 2008; Pascual et al., 2005; Pasti et al., 1997; Serrano et al., 2006; Yang et al., 2003) . The mechanisms underlying Ca 2+ -dependent gliotransmitter release are currently under investigation and remain controversial (Kang et al., 2008; Parpura et al., 2004) . However, exocytotic vesicular release of gliotransmitters has received considerable attention due to its Ca 2+ dependency and potential to occur under physiological conditions (Parpura et al., 2004) . There are many excellent reviews in this area describing the mechanisms and outcomes of gliotransmission in vitro and in situ (Halassa et al., 2007; Haydon and Carmignoto, 2006; Iadecola and Nedergaard, 2007; Ransom et al., 2003; Volterra and Steinhauser, 2004) . The implications of these findings are profound, with astrocytes representing a potential feedforward excitatory or inhibitory influence on neuronal activity. However, the physiological relevance of these results remains unclear, since Ca
2+
-dependent gliotransmission and subsequent modulation of neuronal synaptic activity is both controversial and has not yet been demonstrated to occur in vivo.
The hippocampal circuit, specifically the Schaffer collateral (SC)-CA1 pyramidal neuron synapse (SC-CA1 synapse), has been used extensively to study gliotransmission and therefore provides for facilitated comparison among research groups. Although results obtained at other synapses or in other brain areas should not be diminished, the goal of the following sections is to highlight the key findings concerning gliotransmission at this synapse (i.e., findings showing a causal link between Ca 2+ increases in astrocytes and effect on neuronal activity). With the aim of providing the reader with the most accurate picture of the findings to date, indirect evidence with no clear causality/directionality established will not be presented. In addition, given that astrocytes in vitro are becoming recognized as a poor model of astrocyte-neuron interaction, only data from intact tissue preparations will be presented. that triggers an increase in the frequency of spontaneous excitatory postsynaptic AMPA currents (sEPSCs) of CA1 neurons (Fiacco and McCarthy, 2004) . Incubation with group I mGluR antagonists blocked the astrocyte-induced increase in AMPA sEPSC frequency, suggesting that astrocytically released glutamate activates mGluRs on neighboring SC presynaptic terminals to elevate presynaptic Ca 2+ and increase the probability of neurotransmitter release (Fiacco and McCarthy, 2004) . More recently, it has also been reported that uncaging Ca 2+ in astrocytes elicits the release of glutamate, causing increased glutamate release from 47% of the SC presynaptic terminals studied (Perea and Araque, 2007 triggering the release of ATP that is converted extracellularly into adenosine, which then suppresses glutamate release from presynaptic terminals via the activation of inhibitory presynaptic adenosine receptors (A 1 Rs) (Pascual et al., 2005; Serrano et al., 2006) . The expression of a dominant-negative mutation of synaptobrevin 2 (dnSNARE) to interfere with the vesicular release of ATP/adenosine from astrocytes resulted in a decrease of the tonic suppression of synaptic transmission by A 1 Rs (Pascual et al., 2005) . As a consequence, the dynamic range of synaptic transmission was decreased, leading to an inhibition of LTP in situ. This was a surprising finding given that glutamate, not ATP, has been shown to be released by an exocytotic synaptobrevin 2-dependent process in cultured astroglia (Araque et al., 2000; Zhang et al., 2004) and in situ (Perea and Araque, 2007 (Fiacco and McCarthy, 2004; Perea and Araque, 2007) . Work from Richard Robitaille's laboratory also suggested that increases in astrocytic Ca 2+ trigger ATP/ adenosine release to suppress synaptic transmission at the SC-CA1 synapse (Serrano et al., 2006) . In this situation, electrical stimulation of the SC pathway led to activation of GABAergic interneurons, resulting in release of GABA onto astrocytes to activate GABA B receptors to increase astrocytic Ca 2+ . A rise in astrocytic Ca 2+ was reported to stimulate ATP/adenosine release that activated presynaptic A 1 Rs, suppressing SC presynaptic glutamate release to enhance heterosynaptic depression (Serrano et al., 2006) . In contrast to the above reports, studies using genetic models to either selectively activate astrocytic G q GPCR signaling (MrgA1 transgenic mice) or abolish astrocyte Ca 2+ activity (IP 3 R2 KO mice) failed to find any evidence that astrocytic Ca 2+ affects glutamate release at the SC-CA1 synapse in situ (Fiacco et al., 2007; Petravicz et al., 2008) . Slice perfusion with the ligand that selectively activates MrgA1Rs led to increases in Ca 2+ in 80%-90% of astrocytes but did not result in the modulation of the frequency or amplitude of miniature EPSCs (mEPSCs), indicating that the presynaptic and postsynaptic activity of SC-CA1 synapses were not affected. Experiments performed to determine whether the expression of transgenic MrgA1Rs interfered with gliotransmitter release revealed that this was not the case, since uncaging IP 3 in MrgA1R + astrocytes led to an increase in sEPSCs, similar to findings in wild-type mice. These results demonstrated that glutamate is released from astrocytes following Ca 2+ increases due to IP 3 uncaging, but not when stimulating G q GPCRs to increase astrocytic Ca 2+ . In addition to data obtained using the transgenic MrgA1 astrocytic receptors, activation of endogenous astrocytic G q GPCRs including endothelin receptors and mGluRs was also found to produce no effect in either the amplitude or frequency of sEPSCs or mEPSCs (Fiacco et al., 2007) . It has been recently reported that certain G q GPCRs, such as the purinergic P2Y 1 receptors, are not coupled to the release machinery in astrocytes (Shigetomi et al., 2008) . Therefore, the possibility that activation of transgenic MrgA1Rs and native endothelin and mGlu receptors produces Ca 2+ elevations, which may also be uncoupled from release machinery. However, this hypothesis seems difficult to reconcile with data showing that (1) stimulation of endothelin receptors evokes glutamate release from cultured astroglia (Sasaki et al., 1997) and (2) mGluR-mediated Ca 2+ increases have been reported to produce glutamate release from astrocytes in situ to activate postsynaptic receptors (Angulo et al., 2004; Pasti et al., 1997 ; see following paragraph). Although in the case of these latter studies (Angulo et al., 2004; Pasti et al., 1997 ) the authors did not report any presynaptic effect, which is consistent with the data mentioned above (Fiacco et al., 2007) , it remains unclear as to why mGluR-mediated Ca 2+ increases would affect only the postsynaptic compartment at the SC-CA1 synapse in these studies, while no postsynaptic effect was found by Fiacco et al. (2007) . In addition, it is unclear as to why astrocytic glutamate release that targets presynaptic receptors would be evoked by IP 3 or Ca 2+ uncaging (Fiacco and McCarthy, 2004; Perea and Araque, 2007) while this modulation would not be evoked by stimulation of G q GPCRs (Fiacco et al., 2007) . A rational explanation for these discrepancies will require further study. If astrocytic Ca 2+ elevations regulate glutamate release from astrocytes, it is likely that locking astrocytic cytosolic Ca 2+ concentrations to basal levels would affect neuronal sEPSCs. Knockout of astrocytic IP 3 R2 not only eliminates the ability of astrocytes to respond to agonist application with Ca 2+ elevations but, in addition, these astrocytes exhibit no spontaneous Ca 2+ activity. The frequency and amplitude of sEPSCs measured in CA1 pyramidal neurons derived from wild-type and IP 3 R2 KO mice were compared, and no significant differences were detected (Petravicz et al., 2008) , suggesting that astrocytic Ca 2+ increases are not involved in modulation of neuronal activity. It remains a possibility that astrocytic Ca 2+ does not modulate basal neuronal activity but instead higher levels of neuronal activity so this should be borne in mind. However, it is striking that the absence of astrocytic Ca 2+ activity in the IP 3 R2 KO mice has no apparent effect on brain development, mouse behavior, and spontaneous neuronal synaptic activity, which is in agreement with the idea that astrocytic Ca 2+ increases might not play a central role in astrocyte-to-neuronal interactions (Petravicz et al., 2008) . Overall, these findings indicate that astrocytic gliotransmitter release that affects presynaptic activity can be induced under certain conditions, such as when electrically stimulating SCs (Pascual et al., 2005; Serrano et al., 2006) or using certain pharmacological treatments (e.g., uncaging IP 3 or Ca 2+ in astrocytes; Fiacco and McCarthy, 2004; Perea and Araque, 2007) , but may not be induced when stimulating astrocytic G q GPCRs (Fiacco et al., 2007; Petravicz et al., 2008) .
Gliotransmission and the Regulation of Glutamate Release from Presynaptic Terminals

Gliotransmission and the Direct Activation of Neuronal Postsynaptic Glutamatergic Receptors
Several laboratories have reported that increases in Ca 2+ in a subpopulation of astrocytes leads to the release of glutamate that activates postsynaptic neuronal glutamatergic receptors (Angulo et al., 2004; Jourdain et al., 2007; Kozlov et al., 2006; Lee et al., 2007; Navarrete and Araque, 2008; Pasti et al., 1997; Perea and Araque, 2007; Shigetomi et al., 2008) . At the SC-CA1 synapse, G q GPCR agonist application in the presence of inhibitors of synaptic neurotransmitter exocytosis has been reported to elicit Ca 2+ elevations in a large population of hippocampal astrocytes in situ that immediately precede increases in neuronal Ca
2+
. Neuronal Ca 2+ increases
were blocked in 20% of the neurons by iGluR antagonists, suggesting that glutamate derived from astrocytes was activating neuronal postsynaptic iGluRs in a small population of neurons (Pasti et al., 1997) . Two independent groups using either G q GPCR agonist application, Ca 2+ uncaging and/or mechanical stimulation to increase astrocytic Ca 2+ reported that Ca 2+ -evoked glutamate release from astrocytes induced extrasynaptic NR2B subtype NMDAR-mediated slow inward currents (SICs) in a population of hippocampal CA1 pyramidal neurons to synchronize their activity (Angulo et al., 2004; . To facilitate activation of NMDARs, these experiments were performed in the absence of extracellular magnesium. Approximately 60% of single astrocytes that were mechanically stimulated evoked SICs in an adjacent neuron (Angulo et al., 2004) . In addition, when a large population of astrocytes was stimulated by bath application of G q GPCR agonists, 30% of neurons gave rise to SICs . Under physiological conditions (i.e., 1 mM extracellular magnesium), activation of astrocytes by G q GPCR agonists evoked SICs in a significantly lower percentage of neurons (10%). The occurrence of SICs was unaffected by treatments that block the vesicular release of glutamate from SC terminals, suggesting that the source of glutamate driving neuronal SICs had an astrocytic and not a neuronal origin. The slow kinetics of SICs were attributed to both the longer diffusion distance of glutamate in the extrasynaptic space as opposed to the synaptic cleft and the slower kinetics inherent to NR2B subtype NMDARs. Increases in astrocytic Ca 2+ were thought to be necessary and sufficient to induce glutamate release from astrocytes that directly evoked SICs in CA1 pyramidal neurons . Since these reports, other laboratories have reported that astrocytic Ca 2+ evoked by application of G q GPCR agonists, neuronal depolarization, or astrocyte depolarization leads to glutamate release that activates extrasynaptic NR2B subunit subtype NMDARs on CA1 pyramidal neurons to generate SICs (Navarrete and Araque, 2008; Perea and Araque, 2005; Shigetomi et al., 2008) . Control experiments showed that blocking astrocytic Ca 2+ elevations (by loading astrocytes with Ca 2+ chelators) blocked neuronal SICs, suggesting that astrocytic Ca 2+ increases were necessary to evoke SICs (Navarrete and Araque, 2008; Perea and Araque, 2005) . In these studies, however, the source of glutamate was not directly shown to have a nonneuronal origin (experiments were performed in the presence of presynaptic neurotransmitter release), and therefore, the possibility that glutamate released from neurons contributed to the effect cannot be ruled out (Navarrete and Araque, 2008; Perea and Araque, 2005; Shigetomi et al., 2008) . It should be noted here that SICs were reported to happen spontaneously, in the absence of astrocyte stimulation. In addition, in four of the studies cited above, an increase in SIC frequency associated with astrocytic Ca 2+ elevations was found only in a small fraction (10%-60%) of cells tested (Angulo et al., 2004; Pasti et al., 1997; Shigetomi et al., 2008) . These observations suggest that averaging data together rather than analyzing only the cells showing an effect may have led to a different conclusions (i.e., that astrocytic Ca 2+ elevations would not have correlated significantly to changes in the frequency of SICS). However, two other studies did not mention such a selection criteria (Navarrete and Araque, 2008; Perea and Araque, 2005) and therefore provide a better demonstration for the occurrence of astrocyte-to-neuron signaling through postsynaptic iGluRs.
In contrast to the studies described above, a number of other groups have provided conflicting data about the occurrence of SICs in CA1 neurons or have failed to observe any SICs following astrocytic G q GPCR-mediated Ca 2+ increases. For example, the activation of protease-activated receptor 1 (PAR1) on hippocampal astrocytes was shown to produce astrocytic Ca 2+ increases that caused CA1 neuronal depolarization and enhanced the NMDAR-mediated component of synaptic mEPSCs, evoked EPSCs, and evoked EPSPs, but no evidence of SICs was observed in these recordings (Lee et al., 2007) . Interestingly, a different study showed that activation of astrocytic PAR1 evoked SICs in 60% of CA1 neurons, whereas activation of astrocytic P2Y 1 purinergic receptors did nothing (Shigetomi et al., 2008) . This led the authors to conclude that G q GPCR-mediated increases in astrocytic Ca 2+ and consequent release of glutamate depends on the G q GPCR activated (PAR1 versus P2Y 1 ). Although these results (Lee et al., 2007; Shigetomi et al., 2008) suggest that PAR1 may uniquely tap into processes important in gliotransmitter release, it remains a concern that some investigators observe PAR1-mediated SICs without neuronal depolarizations (Shigetomi et al., 2008) , while others are unable to see SICs but evoke PAR1-mediated neuronal depolarizations (Lee et al., 2007) . It is also a concern that Shigetomi et al. reported no effect of stimulation of astrocytic P2Y 1 receptors, when several studies have reported that ATP stimulation of astrocytes leads to SICs (Angulo et al., 2004; Perea and Araque, 2005) and other effects in neurons (Jourdain et al., 2007; Domercq et al., 2006) , presumably due to activation of P2Y 1 receptors on astrocytes (Jourdain et al., 2007; Domercq et al., 2006) . These discrepancies suggest that there may be some technical variable(s) affecting the ability of astrocytes to release gliotransmitters while also providing clear examples as to why Ca 2+ -dependent glutamate release by astrocytes remains controversial. For example, the possibility that PAR1 agonists might directly activate neurons cannot be ruled out, as there are several reports supporting the expression of PAR1 receptors in both hippocampal neurons and astrocytes in rats and humans (Gingrich et al., 2000; Niclou et al., 1998; Junge et al., 2004; Striggow et al., 2001) . In addition, the criteria (kinetics and amplitude) used for defining SICs by Shigetomi et al. (2008) are different from those previously defined by other investigators. The SICs described by Shigetomi et al. are approximately half the amplitude and twice as fast when compared to previously reported SICs, raising the possibility that they recorded NMDAR-mediated currents that other investigators such as Lee et al. (2007) might not have qualified as SICs but instead as synaptic NMDAR currents. Similarly, most NMDA receptor-dependent EPSCs described by Perea and Araque (2005) (with the exception of the ATP-evoked SICs) are of much smaller amplitude and faster kinetics than SICs described by other groups, making it unclear whether these events are synaptic NMDA mEPSCs or SICs. Overall, due to the difficulty comparing kinetics between groups, it is unclear how many investigators differentiate between synaptic NMDA mEPSCs (which are significantly slower than synaptic AMPA mEPSCs) and SICs. Researchers in the field would benefit from collective agreement on a nomenclature to describe SICs, to facilitate the exchange and the comparison of information and to build a foundation for future progress in the field. Over the course of several years of experiments attempting to replicate these findings, our group has never observed any evidence for Ca 2+ -induced glutamate release from astrocytes activating postsynaptic neuronal receptors. In earlier studies relying primarily on uncaging IP 3 in single astrocytes to stimulate gliotransmitter release, findings indicated that glutamate could indeed be released from astrocytes to activate presynaptic mGluRs but not postsynaptic iGluRs (Fiacco and McCarthy, 2004) . Then, using the MrgA1 mouse model to selectively increase Ca 2+ in a large population of astrocytes, not only were no changes in SC presynaptic transmission detected, but also no changes in postsynaptic CA1 pyramidal neuron activity were observed (Fiacco et al., 2007) . Additionally, stimulating endogenous G q GPCRs such as endothelin receptors or mGluRs failed to induce any detectable SICs or changes in the ambient postsynaptic NMDAR current noise (Fiacco et al., 2007) . Overall, these findings argue that an increase in astrocytic Ca 2+ is not sufficient to induce glutamate release from astrocytes to affect neuronal postsynaptic glutamatergic receptors in situ. These data are conflicting with comparable data from three other groups (discussed in detail above) showing that G q GPCR agonist application results in SICs (Angulo et al., 2004; Shigetomi et al., 2008) . A critical evaluation of the differences among all these results has to be done in order to help resolve what appear to be persistent discrepancies among the primary research groups working on this phenomenon. One notable difference should be pointed out here. Investigators reporting that stimulation of astrocytic Ca 2+ increases triggers SICs (regardless of the stimuli used, including G q GPCR agonist application; Angulo et al., 2004; Navarrete and Araque, 2008; Perea and Araque, 2005; Shigetomi et al., 2008) , have all reported the occurrence of spontaneous SICs in basal conditions independent of astrocytic activity. It is striking to note that the investigators that have not reproduced such data using two kinds of stimuli (IP 3 uncaging or agonist application to stimulate several G q GPCRs) have never recorded any SICs in basal conditions (Fiacco and McCarthy, 2004; Fiacco et al., 2007; Lee et al., 2007) . This raises the possibility that there are other variable(s) in the acute slice preparations that are primarily responsible for the occurrence of SICs. What could be this difference? There may be a combination of several variables from tissue preparation to the content of internal and external solutions. Interestingly, currents similar to the NR2B subtype NMDAR-mediated SICs have been reported to be induced 100% of the time when the osmolarity of the recording buffer is reduced. The SICs induced by a hypo-osmotic shift in buffer are (1) indistinguishable from the large-amplitude, very slow SICs reported by other groups following treatments that increase astrocytic Ca 2+ and (2) occur independent of IP 3 R-dependent astrocytic Ca 2+ increases or presynaptic vesicular release of glutamate (Fiacco et al., 2007) . These results suggest that SIC-like currents are driven predominantly by glutamate release via a pathway that does not involve astrocytic Ca 2+ elevations but involves alterations in cell volume, which are more typical in pathological conditions. In agreement with this hypothesis, another report indicates that perfusion with hypotonic buffer leads to a significant increase in SIC frequency in olfactory bulb neurons (Kozlov et al., 2006) . This latter set of data from different groups (Fiacco et al., 2007; Kozlov et al., 2006) might reconcile the discrepancies found in the literature with the possibility that spontaneous and/or evoked glutamate release from astrocytes might be preferentially associated with certain nonphysiological states of the tissue and might not be necessarily related to Ca 2+ elevations in astrocytes. Finally, investigators in the field would certainly benefit from discussion with other laboratories to determine whether the occurrence of spontaneous SICs is a common phenomenon or not among neurophysiologists outside of the field.
Gliotransmission: Neurophysiology, Neuropathology, or Pharmacology? There is no doubt that under certain experimental conditions astrocytes can release gliotransmitters, such as glutamate or ATP, that activate presynaptic and postsynaptic neuronal metabotropic or ionotropic receptors. As discussed above, there are conflicting data concerning whether or not gliotransmission occurs in situ. Data from several laboratories suggest that gliotransmission occurs and might play an important role in physiology. However, there are also data arguing that gliotransmission does not occur when activating G q GPCRs in situ (Table 1) ; therefore, the significance of gliotransmission in neurophysiology or neuropathology remains unclear (Figure 4) . Three distinct possibilities emerge from these discrepancies with respect to gliotransmission. First, gliotransmission could occur under physiological conditions, and subtle differences in experimental conditions among laboratories may explain the qualitatively different findings reported. Second, gliotransmission may only occur under pathological conditions, and the variability in the health of acutely isolated brain slices or other experimental parameters could account for the different findings reported in this field. Third, we can make gliotransmission occur using nonphysiological stimulations (e.g., mechanical stimulation, Ca 2+ or IP 3 uncaging, depolarization of astrocytes, electrical stimulation of nerve fibers), but this phenomenon does not occur in the absence of such stimulations. There are credible arguments for and against each of these three possibilities. As such, how do we make progress in sorting out these possibilities? All elements of experimental protocols need to be carefully examined in an attempt to define the conditions affecting gliotransmitter release. Reagents should be compared and shared, and reciprocal laboratory visits between investigators obtaining conflicting findings should be carried out. Study of gliotransmission in vivo rather Abbreviations: 2AG, AEA, and MAEA, agonist for endocannabinoid receptors (CB1Rs); DHPG [(S)-3,5-dihydroxyphenylglycine], specific group I mGluR agonist; dnSNARE mouse, transgenic mouse expressing a dominant-negative synaptobrevin 2 protein selectively in astrocytes to block SNARE-dependent exocytosis of gliotransmitters; FLRFa, selective MrgA1R agonist; mGluR, metabotropic glutamate receptor; MrgA1R, transgenic G q GPCR specifically expressed in astrocytes; PAR1, proteinase-activated receptor-1; P2Y 1 , purinergic G q GPCR; tACPD [trans-(+)-1-amino-1,3-ciclopentanedicarboxylic acid], specific group I and II mGluR agonist; TFLLR, selective PAR1 agonist. Notes: (1) mouse translines (wild-type versus transgenic) are listed for experiments performed in transgenic mice. When not listed, experiments were carried out using wild-type rats or mice; (2) CB1Rs are mainly coupled to G i/o proteins that regulate cAMP levels, but these receptors can also be coupled to G q proteins (Lauckner et al., 2005) ; (3) when presynaptic or postsynaptic modulations were not reported, it is indicated as NR in the table. 1 Angulo et al., 2004; 2 Fellin et al., 2004; 3 Fiacco et al., 2007; 4 Pasti et al., 1997; 5 Shigetomi et al., 2008;  that in situ using imaging and electrophysiological methods may partially circumvent the pathology associated with acutely isolated brain slices. Genetic models are likely to be critically important for elucidating the role of gliotransmission in synaptic transmission. However, multiple gene manipulations will be required to ensure that the genetic manipulation is truly affecting the targeted process. Innovative tools (pharmacological and/or genetic) to activate G q GPCR-mediated Ca 2+ elevations selectively in astrocytes need to be generated in order to overcome the caveats associated with the current tools used. A deeper appreciation of the heterogeneity among astrocytes also needs to be considered in the interpretation of findings in this field. It remains possible that subsets of astrocytes, and/or different domains within astrocytes, participate in gliotransmission. As additional investigators begin to address the question of gliotransmission and as new methods are applied, we can expect to attain a better understanding of this process.
Conclusions
In situ and in vivo studies clearly demonstrate that astrocytes express a wide variety of GPCRs that affect a diverse set of signaling cascades, including many different G q GPCRs, which are activated by neurotransmitters released from presynaptic terminals to produce astrocytic Ca 2+ increases (Figure 4) . However, for the most part, the physiological outcome of astrocytic G q GPCR activation remains unclear. Prevailing evidence indicates that spontaneous astrocytic Ca 2+ activity generally remains localized and is unlikely to activate distant astrocytes via intercellular Ca 2+ waves. It is also probable that the level of stimulation of astrocytic G q GPCRs determines the volume of the astrocyte that will participate in the signaling cascade. Whether or not gliotransmission plays a role in neurophysiology or neuropathology or is an artifact of the experimental preparations used in this field is one of the most important questions facing researchers in this area (Figure 4) 
